The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
The therapeutic alliance of tong-xin-luo capsule and conventional antihypertensive therapy on prevention of arteriosclerosis in elderly male patient with hypertension
Author(s): 
Pages: 768-771
Year: Issue:  11
Journal: New Medicine

Keyword:  老年高血压动脉硬化通心络坎地沙坦;
Abstract: 目的:探讨通心络联合常规降压治疗对老年男性高血压患者的抗动脉硬化作用.方法:将65~80岁男性高血压患者81例,随机分为常规降压治疗组(41例,单用坎地沙坦治疗)及通心络联合治疗组(40例,通心络联合坎地沙坦治疗).两组在治疗前后分别检测胰岛素、总睾酮、HDL、血浆同型半胱氨酸(Hcy)水平、颈动脉内中膜厚度(CIMT)等指标.43例血压正常者作为对照组,但不进行治疗.结果:除血压异常外,老年男性高血压患者还有内分泌紊乱、血浆Hcy水平较高和HDL水平较低等的重要特征.与常规降压治疗组比较,通心络联合治疗组能有效地降低收缩压(P<0.05),血浆Hcy水平(P<0.01),有效地升高血浆HDL水平(P<0.05).两种治疗均不能改善CIMT.结论:通心络联合常规降压治疗能明显改善动脉硬化相关的心脑血管疾病风险因素,有利于老年男性高血压患者的抗动脉硬化治疗.
Related Articles
No related articles found